LMAB1073110
SARS-CoV-2 Spike RBD LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | LMAB1073110-Each-of-1 | In Stock | ₹ 42,009.96 |
LMAB1073110 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 42,009.96
GST (18%): ₹ 7,561.793
Total Price: ₹ 49,571.753
Antigen
Spike RBD
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Host Species
Llama
Purification Method
Protein A or G purified from cell culture supernatant
Regulatory Status
RUO
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Applications
Blocking Assay
Clone
L009.1.32H
Dilution
Blockade of Receptor-ligand Interaction 50 ug/mL
Gene Accession No.
YP_009724390.1
Immunogen
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Quantity
100 μg
Primary or Secondary
Primary
Target Species
SARS-CoV-2
Form
Purified
Related Products
Description
- Spike RBD Monoclonal antibody specifically detects Spike RBD in SARS-CoV-2 samples
- It is validated for Blocking Assay
Compare Similar Items
Show Difference
Antigen: Spike RBD
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Host Species: Llama
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: RUO
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Applications: Blocking Assay
Clone: L009.1.32H
Dilution: Blockade of Receptor-ligand Interaction 50 ug/mL
Gene Accession No.: YP_009724390.1
Immunogen: Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Quantity: 100 μg
Primary or Secondary: Primary
Target Species: SARS-CoV-2
Form: Purified
Antigen:
Spike RBD
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Host Species:
Llama
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
RUO
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Applications:
Blocking Assay
Clone:
L009.1.32H
Dilution:
Blockade of Receptor-ligand Interaction 50 ug/mL
Gene Accession No.:
YP_009724390.1
Immunogen:
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Quantity:
100 μg
Primary or Secondary:
Primary
Target Species:
SARS-CoV-2
Form:
Purified
Antigen: Spike RBD
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Host Species: Llama
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: RUO
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Applications: Blocking Assay
Clone: L009.1.32H
Dilution: Blockade of Receptor-ligand Interaction 50 ug/mL
Gene Accession No.: YP_009724390.1
Immunogen: Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Quantity: 25 μg
Primary or Secondary: Primary
Target Species: SARS-CoV-2
Form: Purified
Antigen:
Spike RBD
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Host Species:
Llama
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
RUO
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Applications:
Blocking Assay
Clone:
L009.1.32H
Dilution:
Blockade of Receptor-ligand Interaction 50 ug/mL
Gene Accession No.:
YP_009724390.1
Immunogen:
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Quantity:
25 μg
Primary or Secondary:
Primary
Target Species:
SARS-CoV-2
Form:
Purified
Antigen: Siglec-2/CD22
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Llama
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: RUO
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Applications: Immunocytochemistry
Clone: L007.2.5H
Dilution: Immunocytochemistry 8-25 ug/mL
Gene Accession No.: CAA42006.1
Immunogen: Chinese Hamster Ovary cell line CHO-derived human Siglec-2/CD22 as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody, Asp20-Arg687, Accession # CAA42006.1
Quantity: 100 μg
Primary or Secondary: Primary
Target Species: Human
Form: Purified
Antigen:
Siglec-2/CD22
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Llama
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
RUO
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Applications:
Immunocytochemistry
Clone:
L007.2.5H
Dilution:
Immunocytochemistry 8-25 ug/mL
Gene Accession No.:
CAA42006.1
Immunogen:
Chinese Hamster Ovary cell line CHO-derived human Siglec-2/CD22 as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody, Asp20-Arg687, Accession # CAA42006.1
Quantity:
100 μg
Primary or Secondary:
Primary
Target Species:
Human
Form:
Purified
Antigen: Siglec-2/CD22
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Llama
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: RUO
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Applications: Immunocytochemistry
Clone: L007.2.5H
Dilution: Immunocytochemistry 8-25 ug/mL
Gene Accession No.: CAA42006.1
Immunogen: Chinese Hamster Ovary cell line CHO-derived human Siglec-2/CD22 as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody, Asp20-Arg687, Accession # CAA42006.1
Quantity: 25 μg
Primary or Secondary: Primary
Target Species: Human
Form: Purified
Antigen:
Siglec-2/CD22
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Llama
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
RUO
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Applications:
Immunocytochemistry
Clone:
L007.2.5H
Dilution:
Immunocytochemistry 8-25 ug/mL
Gene Accession No.:
CAA42006.1
Immunogen:
Chinese Hamster Ovary cell line CHO-derived human Siglec-2/CD22 as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody, Asp20-Arg687, Accession # CAA42006.1
Quantity:
25 μg
Primary or Secondary:
Primary
Target Species:
Human
Form:
Purified